Product Reports Resources Pricing Login Book a demo

Agenus

Biotech & Life Sciences · Lexington, United States · Founded 1994 · IPO 2000

Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants

Valuation $318M
Revenue $185M

Talent graph

Agenus's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Agenus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
EW Healthcare Partners
Mentor Capital
Flagship Pioneering
Grazia Equity
BCM Ventures
Advent Life Sciences

Global footprint

Where Agenus has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States84.7%
🇬🇧 United Kingdom11.1%
🇻🇳 Vietnam0.7%
🇨🇱 Chile0.7%
🇶🇦 Qatar0.7%
Top 5 of 9 shown
Web traffic by country
7.7K monthly visits
across markets
🇺🇸 United States45.5%
🇮🇳 India28.6%
🇯🇵 Japan11.7%
🇩🇪 Germany9.1%
🇫🇷 France6.5%
Top 5 markets shown

Patent intelligence

$117M patent portfolio · 84 active families

Estimated portfolio value
$117M
36.7% of market cap · 2.7× smaller than top peer MorphoSys ($321M)
84 active patent families
Where Agenus innovates Anti antibodyAntiendomysial antibodiesAntigenCarcinosisExpression vector

Where Agenus concentrates vs peers

Each axis is a top-10 topic across Agenus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Agenus

An AI-synthesized read of the highest-engagement posts about Agenus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Agenus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.